In Vitro Diagnostics Archives - Pharmaceutical Business review

Pharmaceutical Business review is using cookies

Continue Learn More

Close

In Vitro Diagnostics

16 Aug 2023
- In Vitro Diagnostics
- Approvals
FDA accepts Venatorx’s NDA for cefepime-taniborbactam antibiotic

By PBR Staff Writer

The US Food and Drug Administration (FDA) has accepted Venatorx Pharmaceuticals’ new drug application (NDA) for cefepime-taniborbactam antibiotic for the potential treatment of complicated urinary tract infections (cUTI) including pyelonephritis, in adults.
11 Jan 2021
Drug Discovery
In Vitro Diagnostics
Pfizer says BNT162b2 vaccine is effective against new Covid strains

By PBR Staff Writer

Pfizer and BioNTech said that their Covid-19 vaccine BNT162b2 has been found to be effective against a key mutation found in two highly transmissible strains of the SARS-CoV-2 virus as per the results from an in vitro study.